Wellington Management Group LLP Sells 29,003 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Wellington Management Group LLP lessened its holdings in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 24.7% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 88,343 shares of the company's stock after selling 29,003 shares during the period. Wellington Management Group LLP owned about 0.22% of Phibro Animal Health worth $1,989,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also modified their holdings of PAHC. CWM LLC raised its holdings in shares of Phibro Animal Health by 89.8% during the second quarter. CWM LLC now owns 2,188 shares of the company's stock worth $37,000 after acquiring an additional 1,035 shares in the last quarter. Summit Securities Group LLC bought a new stake in shares of Phibro Animal Health in the 2nd quarter valued at approximately $83,000. Acadian Asset Management LLC increased its holdings in Phibro Animal Health by 6.3% in the second quarter. Acadian Asset Management LLC now owns 717,506 shares of the company's stock worth $12,027,000 after buying an additional 42,299 shares during the last quarter. American Century Companies Inc. raised its position in Phibro Animal Health by 119.6% during the second quarter. American Century Companies Inc. now owns 347,191 shares of the company's stock valued at $5,822,000 after acquiring an additional 189,068 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its stake in Phibro Animal Health by 5.7% in the second quarter. Dimensional Fund Advisors LP now owns 775,470 shares of the company's stock valued at $13,005,000 after acquiring an additional 42,086 shares during the last quarter. Hedge funds and other institutional investors own 99.34% of the company's stock.

Phibro Animal Health Stock Performance

Shares of PAHC traded up $0.54 during mid-day trading on Thursday, hitting $21.81. The company's stock had a trading volume of 277,539 shares, compared to its average volume of 158,133. Phibro Animal Health Co. has a one year low of $10.03 and a one year high of $25.98. The stock's 50-day moving average is $23.63 and its two-hundred day moving average is $20.66. The firm has a market capitalization of $883.37 million, a PE ratio of 50.72, a price-to-earnings-growth ratio of 0.58 and a beta of 0.51. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23.

Phibro Animal Health Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, December 18th. Stockholders of record on Wednesday, November 27th were issued a dividend of $0.12 per share. The ex-dividend date of this dividend was Wednesday, November 27th. This represents a $0.48 annualized dividend and a dividend yield of 2.20%. Phibro Animal Health's payout ratio is 111.63%.

Analyst Ratings Changes

A number of research analysts have recently weighed in on the stock. Morgan Stanley raised their price target on shares of Phibro Animal Health from $20.00 to $25.00 and gave the company an "equal weight" rating in a report on Tuesday. StockNews.com upgraded Phibro Animal Health from a "buy" rating to a "strong-buy" rating in a research note on Wednesday. JPMorgan Chase & Co. began coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They issued a "neutral" rating and a $22.00 price objective on the stock. Bank of America upped their target price on Phibro Animal Health from $13.00 to $15.00 and gave the stock an "underperform" rating in a research report on Friday, August 30th. Finally, Barclays boosted their price objective on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a research note on Tuesday, November 12th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and one has given a strong buy rating to the stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $20.50.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.